Cerebrospinal fluid biomarkers for the differential diagnosis of Alzheimer’s disease

Introduction: Several studies have been conducted in order to validate cerebrospinal fluid biomarkers for the diagnosis of Alzheimer’s disease (AD), aiming primarily to facilitate the early diagnosis. Objective: To evaluate CSF biomarkers on patients with probable AD and the applicability of th...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Jornal Brasileiro de Patologia e Medicina Laboratorial
Auteurs principaux: Carolina A. Magalhães, Micheli Figueiró, Vanessa G. Fraga, Elvis C. Mateo, André A. S. F. Toledo, Maria das Graças Carvalho, Paulo Caramelli, Karina B. Gomes
Format: Artigo
Langue:Inglês
Publié: Sociedade Brasileira de Patologia Clínica/Medicina Laboratorial 2015
Sujets:
Medicina
Amyloid
tau proteins
Alzheimer’s disease
cerebrospinal fluid
Accès en ligne:https://www.redalyc.org/articulo.oa?id=393542989004
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires